BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 14724567)

  • 1. Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells.
    Pennati M; Binda M; Colella G; Zoppe' M; Folini M; Vignati S; Valentini A; Citti L; De Cesare M; Pratesi G; Giacca M; Daidone MG; Zaffaroni N
    Oncogene; 2004 Jan; 23(2):386-94. PubMed ID: 14724567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo.
    Zhang M; Mukherjee N; Bermudez RS; Latham DE; Delaney MA; Zietman AL; Shipley WU; Chakravarti A
    Prostate; 2005 Aug; 64(3):293-302. PubMed ID: 15754318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivin mediates resistance to antiandrogen therapy in prostate cancer.
    Zhang M; Latham DE; Delaney MA; Chakravarti A
    Oncogene; 2005 Apr; 24(15):2474-82. PubMed ID: 15735703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribozyme-mediated down-regulation of survivin expression sensitizes human melanoma cells to topotecan in vitro and in vivo.
    Pennati M; Binda M; De Cesare M; Pratesi G; Folini M; Citti L; Daidone MG; Zunino F; Zaffaroni N
    Carcinogenesis; 2004 Jul; 25(7):1129-36. PubMed ID: 14764461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribozyme-mediated inhibition of PKCalpha sensitizes androgen-independent human prostate cancer cells to cisplatin-induced apoptosis.
    Orlandi L; Binda M; Folini M; Bearzatto A; Villa R; Daidone MG; Zaffaroni N
    Prostate; 2003 Feb; 54(2):133-43. PubMed ID: 12497586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribozyme-mediated cleavage of the human survivin mRNA and inhibition of antiapoptotic function of survivin in MCF-7 cells.
    Choi KS; Lee TH; Jung MH
    Cancer Gene Ther; 2003 Feb; 10(2):87-95. PubMed ID: 12536196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
    Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH
    Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation.
    Yoo J; Lee YJ
    Mol Pharmacol; 2007 Dec; 72(6):1586-92. PubMed ID: 17848598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
    Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
    J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional targeting of tumors with a novel tumor-specific survivin promoter.
    Zhu ZB; Makhija SK; Lu B; Wang M; Kaliberova L; Liu B; Rivera AA; Nettelbeck DM; Mahasreshti PJ; Leath CA; Barker S; Yamaoto M; Li F; Alvarez RD; Curiel DT
    Cancer Gene Ther; 2004 Apr; 11(4):256-62. PubMed ID: 15017380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels.
    Lu M; Strohecker A; Chen F; Kwan T; Bosman J; Jordan VC; Cryns VL
    Clin Cancer Res; 2008 May; 14(10):3168-76. PubMed ID: 18483385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
    Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.
    Gritsko T; Williams A; Turkson J; Kaneko S; Bowman T; Huang M; Nam S; Eweis I; Diaz N; Sullivan D; Yoder S; Enkemann S; Eschrich S; Lee JH; Beam CA; Cheng J; Minton S; Muro-Cacho CA; Jove R
    Clin Cancer Res; 2006 Jan; 12(1):11-9. PubMed ID: 16397018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GLI2 knockdown using an antisense oligonucleotide induces apoptosis and chemosensitizes cells to paclitaxel in androgen-independent prostate cancer.
    Narita S; So A; Ettinger S; Hayashi N; Muramaki M; Fazli L; Kim Y; Gleave ME
    Clin Cancer Res; 2008 Sep; 14(18):5769-77. PubMed ID: 18794086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procaspase 3 expression in ovarian carcinoma cells increases survivin transcription which can be countered with a dominant-negative mutant, survivin T34A; a combination gene therapy strategy.
    McKay TR; Bell S; Tenev T; Stoll V; Lopes R; Lemoine NR; McNeish IA
    Oncogene; 2003 Jun; 22(23):3539-47. PubMed ID: 12789262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
    Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
    Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiosensitization of human melanoma cells by ribozyme-mediated inhibition of survivin expression.
    Pennati M; Binda M; Colella G; Folini M; Citti L; Villa R; Daidone MG; Zaffaroni N
    J Invest Dermatol; 2003 Apr; 120(4):648-54. PubMed ID: 12648230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides.
    Ma X; Wang S; Zhou J; Xing H; Xu G; Wang B; Chen G; Lu YP; Ma D
    Oncol Rep; 2005 Jul; 14(1):275-9. PubMed ID: 15944801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the survivin gene in prostate cancer: correlation with clinicopathological characteristics, proliferative activity and apoptosis.
    Kishi H; Igawa M; Kikuno N; Yoshino T; Urakami S; Shiina H
    J Urol; 2004 May; 171(5):1855-60. PubMed ID: 15076293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.